South Carolina reports 99 new measles cases; now more than 300 cases in Upstate outbreak
On Jan. 12, 2026, a measles outbreak in South Carolina continues to grow, and now neighboring North Carolina is…
-
-
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida
On Jan. 9, 2026, Novartis announced plans to build its fourth US radioligand therapy (RLT) manufacturing facility in…
-
Mount Sinai Researchers Help Create Largest Immune Cell Atlas of Bone Marrow in Multiple Myeloma Patients
On Jan. 9, 2026, scientists at the Icahn School of Medicine at Mount Sinai, in partnership with the Multiple Myeloma Research…
-
Stem cell engineering breakthrough paves way for next-generation living drugs
On Jan. 8, 2026, for the first time, researchers at the University of British Columbia have demonstrated how…
-
Chinese drug makers strike a record US$136 billion in out-licensing deals in 2025
On Jan. 8, 2026, Chinese drug makers’ licensing deals more than doubled in 2025 from a year earlier…
-
Biology | Diagnostics | Disease | Oncology | Therapeutics
New research uncovers critical DNA repair mechanism during cell division
On Jan. 8, 2026, a major advance in cell biology has revealed how our cells safeguard their genetic…
-
How some people get drunk from their own gut bacteria
On Jan. 8, 2026, researchers reported results from a study on the largest cohort of autobrewery syndrome (ABS)…
-
Agriculture | NIH | USDA
New dietary guidelines urge Americans to avoid processed foods and added sugar
On Jan. 7, 2026, Americans should eat more whole foods and protein, fewer highly processed foods and less…
-
US FDA to limit regulation of health and fitness wearables
On Jan. 7, 2026, the U.S. Food and Drug Administration (FDA) said that it will limit regulation of…
-
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases for $1.2 billion
On Jan. 7, 2025, Eli Lilly and Ventyx Biosciences, a San Diego-based clinical-stage biopharmaceutical company focused on developing…
-
CDC | Infectious Disease | Influenza | Measles | Polio | Vaccine | Women's Health
Confusion surrounds CDC’s ‘shared clinical decision-making’ paradigm for childhood vaccines
On Jan. 6, 2025, the Centers for Disease Control and Prevention (CDC) said “shared clinical decision-making” would be…
-
Diagnostics | Environmental | EPA | Forestry | Infectious Disease | Non-Profit Research | Oncology | Therapeutics
respiratory infections remain the world’s leading infectious cause of death
On Jan. 6, 2026, a systematic analysis for the Global Burden of Disease Global study shows that lower…
-
CDC Reports 2025 Measles Outbreak the highest in More Than Thirty Years
On Jan. 6, 2026, the U.S. Centers for Disease Control and Prevention (CDC) reported that for the full…
-
Amgen Acquires Dark Blue Therapeutics for $840 Million
On Jan. 6, 2026, Amgen announced its acquisition of Dark Blue Therapeutics, a privately held biotechnology company based…
-
Four Flu-Related Deaths Among Children in Boston
On Jan. 6, 2026, the Boston Public Health Commission (BPHC) is informing residents that flu has been associated…
-
Some antibodies outmaneuver germs from sticking to cells
On Jan. 6, 2026, a study led by University of Washington School of Medicine researchers uncovered several new…
-
Biotechnology | CDC | Disease | FDA | Vaccine
West Coast Health Alliance Recommends American Academy of Pediatrics Vaccine Schedule
On Jan. 5, 2026, the Acting Director of the Centers for Disease Control and Prevention signed a decision…
-
New “Stomata in-sight” system allows scientists to watch plants breathe in real-time
On Jan. 5, 2026, researchers at the University of Illinois Urbana-Champaign have developed a groundbreaking new tool that…
-
Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
On Jan. 5, 2026, Novo Nordisk announced that the Wegovy® pill is now available, providing those seeking help…
-
Flu season surged in the U.S. over the holiday and already rivals last winter’s harsh epidemic
On Jan. 5, 2026, U.S. flu infections surged over the holidays, and health officials are calling it a…
-
COVID-19 | FDA | Infectious Disease | Influenza | Measles | U.S. Congress | Vaccine
CMS to stop requiring states to report childhood vaccination levels
On Jan. 2, 2026, U.S. states will no longer be required to report how many children they vaccinate…
-
CDC | Diagnostics | Disease | Environmental
Welder’s Anthrax Treated with Obiltoxaximab in Louisiana, fatalities Reported
On Jan. 1, 2026, the Centers for Disease Control and Prevention (CDC) reported that in September 2024, the…
-
US measles outbreak tops 2,000 known infections
On Dec. 29, 2025, measles cases nationwide have reached 2,012, the Centers for Disease Control and Prevention (CDC)…
-
WHO reported Middle East respiratory syndrome coronavirus outbreak continues
On Dec. 24, 2025, the World Health Organization (WHO) reported that since the beginning of 2025 and as…
-
FDA approves Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults
On Dec. 22, 2025, Novo Nordisk announced announced that the US Food and Drug Administration (FDA) has approved…
-
Scientists Map the Human Genome in 4D
On Dec. 22, 2025, scientists at Northwestern University announced a landmark effort to understand how the physical structure…
-
Biotechnology | CMO | CRO | Genomics | Therapeutics | Vaccine
Samsung Biologics Expands U.S. Manufacturing Capabilities with Acquisition of Human Genome Sciences from GSK
On Dec. 21, 2025, Samsung Biologics announced that its wholly owned U.S. subsidiary, Samsung Biologics America, has entered…
-
FDA Announces Approval of Cytokinetics’ MYQORZO™ (aficamten) for Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
On Dec. 19, 2025, Cytokinetics announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ (aficamten),…
-
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Influenza | Measles | Plague | Polio | Vaccine
A century of emergence: trends and patterns in human viral pathogens, 1900–2024, a systematic review
On Dec. 20, 2025, a new study published in the journal BMC Infectious Diseases reported that viral emergence…
-
Novartis and U.S. government reach agreement on lowering drug prices
On Dec. 19, 2025, Novartis, a leading global innovative medicines company, announced it has reached an agreement with…
